Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Investigate the Use of the Plexaa Preconditioning Device (BLOOM43) for Gender Affirming Mastectomy - a Prospective Cohort Study

NCT06502353 is registered in ClinicalTrials.gov with Plexaa Ltd as lead sponsor.

NCT NCT06502353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06502353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Investigate the Use of the Plexaa Preconditioning Device (BLOOM43) for Gender Affirming Mastectomy - a Prospective Cohort Study
Lead sponsor
Plexaa Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
August 20, 2025
Completion date
June 1, 2026
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nipple graft loss, nipple necrosis